R3HDM4 and cancer: R3HDM4 was a clinically relevant prognostic marker: pan-cancer Cox regression linked its high expression to poor OS in KIRC, LAML, LGG; Kaplan-Meier analysis and time-dependent ROC supported its KIRC prognostic value.